Cart
sales@molnova.com
Diphemanil mesylate
CAS No. 62-97-5
Diphemanil mesylate ( —— )
Catalog No. M15380 CAS No. 62-97-5
Diphemanil methylsulfate is a quaternary ammonium anticholinergic.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 28 | In Stock |
|
| 10MG | 36 | In Stock |
|
| 25MG | 57 | In Stock |
|
| 50MG | 71 | In Stock |
|
| 100MG | 93 | In Stock |
|
| 200MG | 136 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDiphemanil mesylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiphemanil methylsulfate is a quaternary ammonium anticholinergic.
-
DescriptionDiphemanil methylsulfate is a quaternary ammonium anticholinergic. It binds muscarinic acetycholine receptors and thereby decreases secretory excretion of stomach acids as well as saliva and sweat.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorAChR
-
Research AreaEndocrinology
-
Indication——
Chemical Information
-
CAS Number62-97-5
-
Formula Weight389.51
-
Molecular FormulaC20H24N·CH3O4S
-
Purity>98%(HPLC)
-
SolubilityWater: 28 mg/mL (71.88 mM); DMSO: 25 mg/mL (64.18 mM)
-
SMILESCOS(O)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Feng G, et al. Int Immunopharmacol. 2015 Apr 15;26(2):392-400.
molnova catalog
related products
-
A 582941 HCl (848591...
A-582941 is a alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing propertiesA-582941 was found to exhibit high-affinity binding and partial agonism at alpha7 nAChRs, with acceptable pharmacokinetic properties and excellent distribution to the central nervous system (CNS).
-
Strychnine Sulfate
In smaller doses, strychnine functions as a stimulant and an athletic performance-enhancer.
-
TBPB
TBPB is an allosteric M1 mAChR agonist(EC50=289 nM) that regulates amyloid processing and produces antipsychotic-like activity in rats.
